268 Journal of Natural Products, 2006, Vol. 69, No. 2
Notes
nm; IR (KBr) νmax 3420, 2879, 1724, 1613, 1516, 1466, 1251, 1136,
Weak Acid Hydrolysis of 3. Compound 3 (1 mg) was treated with
90% HOAc (1 mL) in 90 °C for 4 h, and then the reaction mixture
was freeze-dried. The reaction residue was finally dissolved in MeOH
(0.5 mL) and examined by co-TLC (CHCl3-MeOH, 5:1), in which
compound 6 was detected (Rf 0.50).
1
824 cm-1; H (400 MHz in acetone-d6) and 13C NMR (100 MHz in
acetone-d6), see Table 1; EIMS m/z 502 [M]+ (5), 299 (100), 267 (4),
207 (2), 191 (6), 180 (6), 145 (12), 121 (15), 91 (2); HREIMS m/z
502.1854 [M]+ (calcd for C26H30O10, 502.1839).
Abacopterin B (2): white needles, mp 160-163 °C; [R]25D -18 (c
0.24, MeOH); CD (c 0.0070, MeOH), λ (∆ꢀ) 222 (-6.17), 278 (-1.30)
nm; UV (MeOH) λmax (log ꢀ) 227 (4.32), 274 (3.46), 280 (3.43) nm;
IR (KBr) νmax 3436, 2927, 1726, 1614, 1517, 1466, 1256, 1134, 828
cm-1; 1H (400 MHz in acetone-d6) and 13C NMR (100 MHz in acetone-
d6), see Table 1; EIMS m/z 502 [M]+ (6), 299 (100), 267 (4), 207 (3),
191 (7), 180 (5), 145 (12), 121 (13), 91 (2); ESITOFMS m/z 503.1928
[M + H]+ (calcd for C26H31O10, 503.1917).
Determination of the Absolute Configuration of Sugars.8 Com-
pounds 1-4 (3 mg) were each subjected to acid hydrolysis as described
for 1. The filtrate was examined by TLC with two solvent systems for
sugar analysis (A: CHCl3-MeOH-H2O, 16:9:2; B: EtOAc-n-
BuOH-H2O-HOAc, 4:4:1:1), with Rf values of D-glucose being 0.60
in solvent A and 0.35 in solvent B, respectively. Each remaining filtrate
was freeze-dried to give a residue and dissolved in 100 µL of dry
pyridine, to which was added 200 µL of L-cysteine methyl ester
hydrochloride (0.1 M). The mixture was stirred at 60 °C for 1 h, then
150 µL of hexamethyldisilazane-trimethylchlorosilane (2:1) was added,
and the mixture was stirred at 60 °C for another 30 min. After
centrifugation, the supernatant was directly subjected to GC analysis.
The sugar derivatives obtained from compounds 1-4 showed a single
peak (tR at 24.10 min) comparable with that of a D-glucose derivative,
and the retention time of the L-glucose derivative was 25.06 min.
Abacopterin C (3): white needles, 194-196 °C; [R]25D -16 (c 0.26,
MeOH); CD (c 0.0034, MeOH), λ (∆ꢀ) 226 (-5.09), 278 (-1.59) nm;
UV (MeOH) λmax (log ꢀ) 227 (4.24), 274 (3.52), 280 (3.50) nm; IR
(KBr) νmax 3411, 2929, 1613, 1517, 1467, 1250, 1133, 1080, 826 cm-1
;
1H (400 MHz in DMSO-d6) and 13C NMR (100 MHz in DMSO-d6),
see Table 1; EIMS m/z 460 [M]+ (7), 299 (100), 267 (5), 207 (2), 191
(7), 180 (6), 145 (11), 121 (15), 91 (2); HREIMS m/z 460.1725 [M]+
(calcd for C24H28O9, 460.1733).
Abacopterin D (4): white needles, mp 278-280 °C; [R]25 +18
Cytotoxicity Bioassay. Cytotoxic activity was determined against
a human hepatoblastoma cell line (HepG 2) using the MTT method,9
according to a previously described procedure.10 The OD value was
read on a plate reader at a wavelength of 570 nm. 5-Fluorouracil was
used as the positive control.
D
(c 0.20, MeOH); CD (c 0.0048, MeOH), λ (∆ꢀ) 224 (-1.80), 233 (0),
239 (+0.89), 282 (+1.32) nm; UV (MeOH) λmax (log ꢀ) 227 (4.32),
275 (3.42), 281 (3.40) nm; IR (KBr) νmax 3422, 2926, 1610, 1517, 1461,
1252, 1133, 1085, 834 cm-1; 1H (400 MHz in DMSO-d6) and 13C NMR
(100 MHz in DMSO-d6), see Table 2; EIMS m/z 638 [M]+ (1), 458
(18), 297 (100), 282 (20), 267 (7), 181 (30), 134(58), 121 (23), 91 (7),
Acknowledgment. The authors are grateful to the members of the
analytical group in Shanghai Institute of Materia Medica, Shanghai
Institutes for Biological Sciences, Chinese Academy of Sciences, for
measurements of the mass and NMR spectra.
83 (9); ESITOFMS m/z 661.2103 [M + Na]+ (calcd for C30H38O15
+
Na, 661.2108).
Triphyllin A (5): colorless prisms, mp 197-200 °C; [R]25 +19
D
(c 0.26, MeOH); CD (c 0.0038, MeOH), λ (∆ꢀ) 224 (-3.22), 233 (0),
239 (+1.71), 281 (+1.43) nm; UV (MeOH) λmax (log ꢀ) 227 (4.33),
276 (3.36), 281 (3.36) nm; IR (KBr) νmax 3401, 2920, 1602, 1517, 1458,
1250, 1152, 1074, 835 cm-1; 1H NMR (400 MHz in DMSO-d6) δ 7.40
(2H, d, J ) 8.4 Hz, H-2′ and H-6′), 6.98 (2H, d, J ) 8.4 Hz, H-3′ and
H-5′), 5.25 (1H, brd, J ) 13.0 Hz, H-2), 5.08 (1H, d, J ) 7.6 Hz,
H-1′′), 4.95 (1H, brs, H-4), 4.70, 4.56 (each 1H, d, J ) 12.5 Hz,
CH2OH-6), 4.60 (1H, d, J ) 7.6 Hz, H-1′′′), 3.77 (3H, s, OCH3-4′),
2.14 (3H, s, CH3-8), 2.08 (1H, brd, J ) 13.0 Hz, H-3a), 1.86 (1H, brt,
J ) 12.0 Hz, H-3b); 13C NMR (100 MHz in DMSO-d6) δ 72.2 (CH,
C-2), 36.5 (CH2, C-3), 56.9 (CH, C-4), 152.0 (C, C-5), 120.9 (C, C-6),
154.1 (C, C-7), 115.7 (C, C-8), 152.8 (C, C-9), 115.5 (C, C-10), 53.0
(CH2, CH2OH-6), 9.5 (CH3, CH3-8), 133.3 (C, C-1′), 127.5 (CH, C-2′
and C-6′), 113.9 (CH, C-3′ and C-5′), 158.9 (C, C-4′), 55.1 (CH3, 4′-
OCH3), 104.1 (CH, C-1′′), 73.9 (CH, C-2′′), 76.2 (CH, C-3′′), 70.0
(CH, C-4′′), 77.0 (CH, C-5′′), 60.9 (CH2, C-6′′), 103.7 (CH, C-1′′′),
73.9 (CH, C-2′′′), 76.1 (CH, C-3′′′), 70.0 (CH, C-4′′′), 76.5 (CH, C-5′′′),
60.9 (CH2, C-6′′′); ESIMS m/z 679 [M + Na]+, 477 [M - Glc + H]+,
297 [M - 2Glc + H]+.
Acid Hydrolysis of 1. A solution of 1 (30 mg) in 9% HCl (2 mL)
was stirred at 90 °C for 5 h. After being cooled to 2-4 °C, the reaction
mixture was filtered. The product was chromatographed on a silica
gel (300-400 mesh, 10 g) column (CHCl3-MeOH, 15:1) to yield 1a
(5 mg).
Alkaline Hydrolysis of 1 and 2. Compounds 1 and 2 (0.5 mg) were
each hydrolyzed with 1% aqueous KOH (0.5 mL) for 1 h at room
temperature. The reaction mixture was adjusted to pH 6 with dilute
1% HCl and then extracted with EtOAc (3 × 0.5 mL). Evaportation of
the EtOAc gave compound 3, analyzed by co-TLC (petroleum-acetone,
1:1, Rf 0.30).
Supporting Information Available: CD spectra of compounds 1-5
and spectroscopic data of compound 6. These materials are available
References and Notes
(1) The Institute of Botany Chinese Academy of Sciences. Spore
Morphology of Chinese Ferns; Science Press: Beijing, 1976; pp
264-266.
(2) Ding, H. S. The Medicinal Spore Plants of China; Shanghai Scientific
and Technical Publishers: Shanghai, 1982; pp 124-125.
(3) New Medical Jiangsu College. Dictionary of Chinese Traditional
Medicine; Shanghai Scientific and Technical Publishers: Shanghai,
1977; p 1633.
(4) Tanaka, N.; Murakami, T.; Wada, H.; Gutierrez, A. B.; Saiki, Y.;
Chen, C. M. Chem. Pharm. Bull. 1985, 33, 5231-5238.
(5) Tanaka, N.; Sada, T.; Murakami, T.; Saiki, Y.; Chen, C. M. Chem.
Pharm. Bull. 1984, 32, 490-496.
(6) Tanaka, N.; Ushioda, T.; Fuchino, H.; Braggins, J. E. Aust. J. Chem.
1997, 50, 329-332.
(7) Pouget, C.; Fagnere, C.; Basly, J. P.; Leveque, H.; Chulia, A. J.
Tetrahedron 2000, 56, 6047-6052.
(8) Hara, S.; Okabe, H.; Mihashi, K. Chem. Pharm. Bull. 1986, 34,
1843-1845.
(9) Xu, S. J.; Bian, R. L.; Chen X. The Methodology of Pharmacological
Experiments, 3rd ed.; People’s Medical Publishing House: Beijing,
2002; pp 1784-1786.
(10) Tang, M. J.; Shen D. D.; Hu, Y. C.; Gao, S.; Yu, S. S. J. Nat. Prod.
2004, 67, 1969-1974.
NP050191P